RxDoctor Payments Data

Guang Fan, MD

Hematology · Portland, ORNPI 1750399283

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $4,250 of the $6,774 with a category attached, or 62.7%. Cepheid accounts for 85.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $5,651 and has fallen 86.5% since, to $764 in 2025.

$6,774in general payments, 2019–2025

Across 17 payments — averaging $398.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cepheid$6K
  • Beckman Coulter, Inc.$764
  • Roche Diagnostics Corporation$178
  • E.r. Squibb & Sons, L.L.C.$59
$81,372in research payments, 2019–2025

Across 6 payments — averaging $13,562 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Roche Diagnostics Corporation$81K

What the payments were for

  • Speaking & faculty fees$4,25063%
  • Travel & lodging$1,74426%
  • Food & beverage$78012%

General payments by program year

19
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,774 in reported general payments places this provider in the 70th percentile of 27 hematology providers in Oregon.

See all hematology providers in Oregon

Medicare billing

Part B allowed, 2024
$11,752
Medicare patients
58
Services billed
279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →